First Time Loading...

Global Blood Therapeutics Inc
NASDAQ:GBT

Watchlist Manager
Global Blood Therapeutics Inc Logo
Global Blood Therapeutics Inc
NASDAQ:GBT
Watchlist
Price: 68.49 USD Market Closed
Updated: May 8, 2024

Global Blood Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Global Blood Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Global Blood Therapeutics Inc
NASDAQ:GBT
Cash from Investing Activities
-$390.8m
CAGR 3-Years
-21%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-76%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.8B
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$4.6B
CAGR 3-Years
-89%
CAGR 5-Years
-21%
CAGR 10-Years
-26%

See Also

What is Global Blood Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-390.8m USD

Based on the financial report for Jun 30, 2022, Global Blood Therapeutics Inc's Cash from Investing Activities amounts to -390.8m USD.

What is Global Blood Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-15%

The average annual Cash from Investing Activities growth rates for Global Blood Therapeutics Inc have been -21% over the past three years , -15% over the past five years .